Capital Advisory Group Advisory Services, LLC Catalyst Biosciences, Inc. Transaction History

Capital Advisory Group Advisory Services, LLC

  • $210 Million
  • Q1 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 15, 2022
SELL
$0.91 - $4.16 $910 - $4,160
-1,000 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$3.76 - $8.01 $3,760 - $8,010
1,000 New
1,000 $6,000

Others Institutions Holding CBIO

# of Institutions
1
Shares Held
215
Call Options Held
0
Put Options Held
0
View Full List

About CATALYST BIOSCIENCES, INC.

CBIO Quotes by TradingView
  • Ticker CBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,477,100
  • Description
  • Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...
More about CBIO
Track This Portfolio

Track Capital Advisory Group Advisory Services, LLC Portfolio

Follow Capital Advisory Group Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Advisory Group Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Advisory Group Advisory Services, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email